Nature Reviews Clinical Oncology
Vol. 22, Issue 7
Issue 7
2025
10
Articles
Articles in this Issue
Prospective comparisons support the use of navigational bronchoscopy
Peter Sidaway
Jul 01, 2025
pp. 460-460
10.1038/s41571-025-01039-5
Benefit from huCAR19-IL18 cells in patients with CD19+ lymphomas after CAR T cells
Diana Romero
Jul 01, 2025
pp. 460-460
10.1038/s41571-025-01036-8
Tumour and microenvironment crosstalk in NSCLC progression and response to therapy
Zahraa Rahal, Roy El Darzi, Seyed Javad Moghaddam et al.
Jul 01, 2025
pp. 463-482
10.1038/s41571-025-01021-1
Targeting the glioblastoma resection margin with locoregional nanotechnologies
Thomas Kisby, Gerben R. Borst, David J. Coope et al.
Jul 01, 2025
pp. 517-537
10.1038/s41571-025-01020-2
Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention
Ya-Qi Gao, Yong-Jie Tan, Jing-Yuan Fang
Jul 01, 2025
pp. 499-516
10.1038/s41571-025-01026-w
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer
Franz Rödel, Maximilian Fleischmann, Markus Diefenhardt et al.
Jul 01, 2025
pp. 483-498
10.1038/s41571-025-01025-x
Promising results with zongertinib in advanced-stage HER2-mutant NSCLC
Diana Romero
Jul 01, 2025
pp. 459-459
10.1038/s41571-025-01030-0
Next-generation KRAS-G12C inhibitor D3S-001 shows promise
David Killock
Jul 01, 2025
pp. 459-459
10.1038/s41571-025-01028-8
The evolving immuno-angiogenic paradigm in NSCLC: lessons from ivonescimab
Roy S. Herbst, Lieping Chen
Jul 01, 2025
pp. 461-462
10.1038/s41571-025-01024-y
FDA approvals in 2024: new options for patients across cancer types and therapeutic classes
Sundeep Agrawal, Esther Park, Paul G. Kluetz
Jul 01, 2025
pp. 457-458
10.1038/s41571-025-01018-w
All Issues
Journal Info
Publisher
Springer Science and Business Media LLC
ISSN
1759-4774
E-ISSN
1759-4782
Subject
Medicine
Language
English